News

Halozyme sues Merck; FDA blames cuts for Vanda delay
Halozyme claims Merck infringed on patents in developing a subcutaneous form of Keytruda. Elsewhere, Vanda’s challenge to an ...
Halozyme Sues Merck for Patent Infringement over Subcutaneous Keytruda Formulation
Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme), a biotechnology company that pioneered the use of human hyaluronidase ...
Halozyme files patent lawsuit against Merck over injectable Keytruda
Merck (MRK) stock trades flat as Halozyme Therapeutics (HALO) files patent infringement suit linked to MRK's new injectable ...
Fierce Pharma3d
Halozyme sues Merck over subcutaneous Keytruda as licensing talks fall through
Halozyme is not holding back against Merck & Co. in the companies' injectable Keytruda patent dispute, having now escalated a ...
1HALO : Deep Dive Into Halozyme Therapeutics Stock: Analyst Perspectives (5 Ratings)
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...
The Pharma Letter2d
Halozyme files lawsuit against Merck over SC Keytruda
California-based biotech Halozyme Therapeutics (Nasdaq: HALO) yesterday revealed it has filed a patent infringement lawsuit ...
Halozyme sues Merck for patent infringement over subcutaneous Keytruda
Halozyme (HALO) filed a patent infringement lawsuit against Merck (MRK) in U.S. District Court in New Jersey. Halozyme believes the ...
Merck Faces Patent Lawsuit Over Easier-to-Use Keytruda
A biotech company is suing to block Merck & Co. from launching an easier-to-use version of its blockbuster cancer treatment ...
Investing3d
Halozyme sues Merck over alleged patent infringement
SAN DIEGO - Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology firm specializing in drug delivery technology, has filed a lawsuit against pharmaceutical giant Merck Sharp & Dohme Corp ...